中华骨科杂志
中華骨科雜誌
중화골과잡지
CHINESE JOURNAL OF ORTHOPAEDICS
2014年
1期
48-55
,共8页
何磊%戎利民%董健文%刘斌%陈瑞强%谢沛根%冯丰%杨补
何磊%戎利民%董健文%劉斌%陳瑞彊%謝沛根%馮豐%楊補
하뢰%융이민%동건문%류빈%진서강%사패근%풍봉%양보
脊柱融合术%腰椎%椎间盘退行性变
脊柱融閤術%腰椎%椎間盤退行性變
척주융합술%요추%추간반퇴행성변
Spinal fusion%Lumbar vertebrae%Intervertebral disc degeneration
目的 探讨极外侧椎体间融合术(extreme lateral interbody fusion,XLIF)治疗腰椎退行性疾病的近期疗效及安全性.方法 回顾性分析2009年9月至2013年1月采用XLIF手术治疗的16例腰椎退行性疾病患者的病例资料,男6例,女10例;年龄36~82岁,平均62岁.腰椎失稳症9例,腰椎管狭窄症7例.所有病例在接受XLIF手术的同时均辅助后路经皮椎弓根钉棒系统固定,其中单节段、双节段和三节段融合者分别为11例、4例和1例.采用疼痛视觉模拟评分(visu-al analogue scale,VAS)、Oswestry功能障碍指数(Oswestry disability index,ODI)和Macnab标准进行疗效评价;通过腰椎正侧位X线片和CT扫描观察融合情况,并记录手术时间、术中出血量和围手术期并发症.结果 单个节段完成椎间盘处理并植入融合器的平均手术时间为75 min,平均术中失血量为83 ml.2例患者术后即出现大腿麻木和屈髋乏力,未行特殊处理,2周后症状消失.所有患者均获得随访,随访时间6~48个月,平均15个月.术后6个月腰痛、腿痛VAS评分较术前平均降低4.6、3.1分,ODI指数较术前平均改善50%,差异有统计学意义.Macnab疗效评定:优9例、良5例、可2例,优良率87.5%(14/16).术后6个月4例完全融合、11例部分融合、1例未融合;随访12个月以上的8例中7例于术后1年完全融合、1例部分融合,融合率87.5%(7/8).结论 XLIF手术安全可行,近期疗效好,可用于治疗腰椎退行性疾病.
目的 探討極外側椎體間融閤術(extreme lateral interbody fusion,XLIF)治療腰椎退行性疾病的近期療效及安全性.方法 迴顧性分析2009年9月至2013年1月採用XLIF手術治療的16例腰椎退行性疾病患者的病例資料,男6例,女10例;年齡36~82歲,平均62歲.腰椎失穩癥9例,腰椎管狹窄癥7例.所有病例在接受XLIF手術的同時均輔助後路經皮椎弓根釘棒繫統固定,其中單節段、雙節段和三節段融閤者分彆為11例、4例和1例.採用疼痛視覺模擬評分(visu-al analogue scale,VAS)、Oswestry功能障礙指數(Oswestry disability index,ODI)和Macnab標準進行療效評價;通過腰椎正側位X線片和CT掃描觀察融閤情況,併記錄手術時間、術中齣血量和圍手術期併髮癥.結果 單箇節段完成椎間盤處理併植入融閤器的平均手術時間為75 min,平均術中失血量為83 ml.2例患者術後即齣現大腿痳木和屈髖乏力,未行特殊處理,2週後癥狀消失.所有患者均穫得隨訪,隨訪時間6~48箇月,平均15箇月.術後6箇月腰痛、腿痛VAS評分較術前平均降低4.6、3.1分,ODI指數較術前平均改善50%,差異有統計學意義.Macnab療效評定:優9例、良5例、可2例,優良率87.5%(14/16).術後6箇月4例完全融閤、11例部分融閤、1例未融閤;隨訪12箇月以上的8例中7例于術後1年完全融閤、1例部分融閤,融閤率87.5%(7/8).結論 XLIF手術安全可行,近期療效好,可用于治療腰椎退行性疾病.
목적 탐토겁외측추체간융합술(extreme lateral interbody fusion,XLIF)치료요추퇴행성질병적근기료효급안전성.방법 회고성분석2009년9월지2013년1월채용XLIF수술치료적16례요추퇴행성질병환자적병례자료,남6례,녀10례;년령36~82세,평균62세.요추실은증9례,요추관협착증7례.소유병례재접수XLIF수술적동시균보조후로경피추궁근정봉계통고정,기중단절단、쌍절단화삼절단융합자분별위11례、4례화1례.채용동통시각모의평분(visu-al analogue scale,VAS)、Oswestry공능장애지수(Oswestry disability index,ODI)화Macnab표준진행료효평개;통과요추정측위X선편화CT소묘관찰융합정황,병기록수술시간、술중출혈량화위수술기병발증.결과 단개절단완성추간반처리병식입융합기적평균수술시간위75 min,평균술중실혈량위83 ml.2례환자술후즉출현대퇴마목화굴관핍력,미행특수처리,2주후증상소실.소유환자균획득수방,수방시간6~48개월,평균15개월.술후6개월요통、퇴통VAS평분교술전평균강저4.6、3.1분,ODI지수교술전평균개선50%,차이유통계학의의.Macnab료효평정:우9례、량5례、가2례,우량솔87.5%(14/16).술후6개월4례완전융합、11례부분융합、1례미융합;수방12개월이상적8례중7례우술후1년완전융합、1례부분융합,융합솔87.5%(7/8).결론 XLIF수술안전가행,근기료효호,가용우치료요추퇴행성질병.
Objective To investigate the short-term clinical effect and safety of extreme lateral interbody fusion (XLIF) for the treatment of lumbar degenerative diseases.Methods Sixteen patients (6 males and 10 females) with an average age of 62 (36 to 82) years were included,consisting of lumbar spinal instability in 9 cases and lumbar spinal stenosis in 7 cases.All patients had undergone XLIF procedure with posterior percutaneous pedicle screw fixation from September 2009 to January 2013.The fusion level was one in 11 cases,two in 4 cases,and three in 1 case.The visual analogue scale (VAS),Oswestry disability index (ODI) and Macnab criteria were used to assess the clinical effect postoperatively while X-ray and CT were used to evaluate the fusion.The operation time,blood loss and postoperative complications were also analyzed.Results Mean operation time and blood loss for discectomy and interbody placement was 75 min and 83 ml per level.We found transient thigh numbness and weakness of hip flexor in 2 cases,which resumed automatically within 2 weeks.All patients were followed up for an average of 15 (6 to 48) months.The VAS score was 4.6 and 3.1 lower in back pain and leg pain while ODI score was 50% lower in six months postoperatively.According to the Macnab criteria,the excellent and good rate was 87.5%.There were 4 complete fusion cases and 11 partial fusion cases in 6 months.7 cases out of 8 achieved complete fusion while 1 case achieved partial fusion after 12 months.The fusion rate was 87.5%.Conclusion XLIF can provide a satisfactory short-term outcome for the treatment of lumbar degenerative diseases.